FRET measurements between small numbers of molecules identifies subtle changes in receptor interactions
暂无分享,去创建一个
H. Steven Wiley | Haluk Resat | Steven D. Colson | Galya Orr | Dehong Hu | Serdar Ozcelik | Chii-Shiarng Chen | Greg S. Harms | Lee K. Opresko | H. Wiley | S. Colson | L. Opresko | H. Resat | Dehong Hu | G. Orr | S. Ozcelik | G. Harms | Serdar Özçelik | Chii‐Shiarng Chen
[1] Sándor Damjanovich,et al. Lipid rafts and the local density of ErbB proteins influence the biological role of homo- and heteroassociations of ErbB2 , 2002, Journal of Cell Science.
[2] Michael Kofler,et al. The crystal structure of a truncated ErbB2 ectodomain reveals an active conformation, poised to interact with other ErbB receptors. , 2003, Molecular cell.
[3] Edouard C. Nice,et al. Crystal Structure of a Truncated Epidermal Growth Factor Receptor Extracellular Domain Bound to Transforming Growth Factor α , 2002, Cell.
[4] S. Weiss. Fluorescence spectroscopy of single biomolecules. , 1999, Science.
[5] H. Blau,et al. Monitoring protein-protein interactions in intact eukaryotic cells by beta-galactosidase complementation. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[7] Gaudenz Danuser,et al. FRET or no FRET: a quantitative comparison. , 2003, Biophysical journal.
[8] Michelle Palmer,et al. Epidermal growth factor receptor dimerization monitored in live cells , 2000, Nature Biotechnology.
[9] H. Steven Wiley,et al. Quantitative Analysis of HER 2-mediated Effects on HER 2 and Epidermal Growth Factor Receptor Endocytosis DISTRIBUTION OF HOMO-AND HETERODIMERS DEPENDS ON RELATIVE HER 2 LEVELS * , 2003 .
[10] T M Jovin,et al. Oligomerization of epidermal growth factor receptors on A431 cells studied by time-resolved fluorescence imaging microscopy. A stereochemical model for tyrosine kinase receptor activation , 1995, The Journal of cell biology.
[11] Douglas Lauffenburger,et al. Coregulation of epidermal growth factor receptor/human epidermal growth factor receptor 2 (HER2) levels and locations: quantitative analysis of HER2 overexpression effects. , 2003, Cancer research.
[12] A. M. Stanley,et al. Structure of the extracellular region of HER 2 alone and in complex with the Herceptin Fab , 2022 .
[13] Manfred Dietel,et al. Involvement of the c‐erbB‐2 oncogene product in the egf‐induced cell motility of sk‐ov‐3 ovarian cancer cells , 1999 .
[14] Thomas Schmidt,et al. Simultaneous dual-color and dual-polarization imaging of single molecules , 2000 .
[15] S. Michnick,et al. Oligomerization domain-directed reassembly of active dihydrofolate reductase from rationally designed fragments. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[16] Jae-Hoon Kim,et al. Crystal Structure of the Complex of Human Epidermal Growth Factor and Receptor Extracellular Domains , 2002, Cell.
[17] Hyun-soo Cho,et al. EGF activates its receptor by removing interactions that autoinhibit ectodomain dimerization. , 2003, Molecular cell.
[18] G. G. Stokes. "J." , 1890, The New Yale Book of Quotations.
[19] Andrew B. Martin,et al. Single-molecule protein folding: diffusion fluorescence resonance energy transfer studies of the denaturation of chymotrypsin inhibitor 2. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[20] M Dahan,et al. Single-pair fluorescence resonance energy transfer on freely diffusing molecules: observation of Förster distance dependence and subpopulations. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[21] G. Assmann,et al. c‐erbB‐2/EGFR as dominant heterodimerization partners determine a motogenic phenotype in human breast cancer cells , 1999, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[22] Jie Leng,et al. ErbB2 Is Necessary for Induction of Carcinoma Cell Invasion by Erbb Family Receptor Tyrosine Kinases , 2000, The Journal of cell biology.
[23] I. Wilson,et al. Erythropoietin receptor activation by a ligand-induced conformation change. , 1999, Science.
[24] C R King,et al. erbB-2 is a potent oncogene when overexpressed in NIH/3T3 cells. , 1987, Science.
[25] D. Lauffenburger,et al. Quantitative Analysis of HER2-mediated Effects on HER2 and Epidermal Growth Factor Receptor Endocytosis , 2003, Journal of Biological Chemistry.
[26] S J Lockett,et al. EGF-induced redistribution of erbB2 on breast tumor cells: flow and image cytometric energy transfer measurements. , 1998, Cytometry.
[27] G. Schütz,et al. Direct observation of ligand colocalization on individual receptor molecules. , 1998, Biophysical journal.
[28] Jie Leng,et al. ErbB 2 Is Necessary for Induction of Carcinoma Cell Invasion by ErbB Family Receptor Tyrosine Kinases , 2000 .